Jian Cui
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Jian Cui has a total of 14 co-authors. Here are the top co-authors by number of shared publications:
Guibin Zhao
Department of Thoracic Surgery, The Fourth Affiliated Hospital, Harbin Medical University, Harbin, 150001, Heilongjiang Province, China
2 shared publicationsShouqiang Cao
Harbin Medical University
2 shared publications- Guibin Zhao
Department of Thoracic Surgery, The Fourth Affiliated Hospital, Harbin Medical University, No.37, Yi yuan Street, Nan gang District, Harbin, Heilongjiang Province, 150001, China
1 shared publication Jingquan Han
Department of Thoracic Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China
1 shared publication- Jingquan Han
Department of Thoracic Surgery, The Fourth Affiliated Hospital, Harbin Medical University, No.37, Yi yuan Street, Nan gang District, Harbin, Heilongjiang Province, 150001, China
1 shared publication Jiyao Li
Department of Thoracic Surgery, the Fourth Affiliated Hospital of Harbin Medical University, Harbin 150001, China
1 shared publication
Latest Publications
- 26 September 2013
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 22 (2) , 351-358
Fast-track surgery improves postoperative clinical recovery and reduces postoperative insulin resistance after esophagectomy for esophageal cancer
This study aims to investigate the influence of fast-track surgery (FTS) on insulin resistance indicators in a prospective randomized, controlled clinical trial in esophageal cancer patients. Between November 2009 and March 2011, 34 patients underwent the FTS pathway, and 34 patients underwent the conventional pathway after esophagectomy in our department. The times to postoperative flatus and defecation, duration of postoperative hospital stay, hospitalization expenditures, and postoperative complications were recorded. Insulin resistance indicators were measured before operation as well as on the 1st, 3rd, and 7th postoperative days (PODs), including serum levels of fasting blood glucose (FBG), fasting insulin (FINS), interleukin-6 (IL-6), and C-reactive protein (CRP) in patients of both groups. The insulin resistance index (homeostasis model assessment of insulin resistance (HOMA-IR)) was calculated at each time point. We found a significantly shorter postoperative hospital stay and faster return of gastrointestinal function in patients who underwent FTS (P < 0.01). In addition, the total hospitalization expenditure was significantly lower in the FTS group (P < 0.01). The preoperative insulin resistance indicators showed no significant differences between the two groups. On PODs 1 and 3, the levels of log-HOMA-IR, FINS, IL-6, and CRP in the FTS group were significantly lower than those in the control group (all P < 0.05). On POD 7, the CRP level in the FTS group was significantly lower than that in the control group (P < 0.05). FTS promotes early recovery of gastrointestinal function and reduces stress reaction and postoperative insulin resistance after esophagectomy for esophageal cancer.
- 26 September 2013
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 22 (2) , 351-358
Fast-track surgery improves postoperative clinical recovery and reduces postoperative insulin resistance after esophagectomy for esophageal cancer
This study aims to investigate the influence of fast-track surgery (FTS) on insulin resistance indicators in a prospective randomized, controlled clinical trial in esophageal cancer patients. Between November 2009 and March 2011, 34 patients underwent the FTS pathway, and 34 patients underwent the conventional pathway after esophagectomy in our department. The times to postoperative flatus and defecation, duration of postoperative hospital stay, hospitalization expenditures, and postoperative complications were recorded. Insulin resistance indicators were measured before operation as well as on the 1st, 3rd, and 7th postoperative days (PODs), including serum levels of fasting blood glucose (FBG), fasting insulin (FINS), interleukin-6 (IL-6), and C-reactive protein (CRP) in patients of both groups. The insulin resistance index (homeostasis model assessment of insulin resistance (HOMA-IR)) was calculated at each time point. We found a significantly shorter postoperative hospital stay and faster return of gastrointestinal function in patients who underwent FTS (P < 0.01). In addition, the total hospitalization expenditure was significantly lower in the FTS group (P < 0.01). The preoperative insulin resistance indicators showed no significant differences between the two groups. On PODs 1 and 3, the levels of log-HOMA-IR, FINS, IL-6, and CRP in the FTS group were significantly lower than those in the control group (all P < 0.05). On POD 7, the CRP level in the FTS group was significantly lower than that in the control group (P < 0.05). FTS promotes early recovery of gastrointestinal function and reduces stress reaction and postoperative insulin resistance after esophagectomy for esophageal cancer.
- Open Access
- 1 April 2013
- Vol. 16 (4) , 169-176
EGF通过STAT5调控肺腺癌A549细胞中COX-2的机制
已有的研究表明COX-2在肺癌发生发展过程中起关键作用, 它被一些细胞因子和生长因子所诱导产生, 并受到JAK/STAT等信号通路的调控, 抑制COX-2的表达能阻止肺癌的发展。本研究旨在探讨表皮生长因子(epidermal growth factor, EGF)在人肺腺癌A549细胞中对STAT5激活效应, 以及STAT5信号通路对COX-2调控机制。 应用免疫荧光法及Western印迹法检测人肺腺癌A549细胞中EGF对STAT5的激活现象。分别用野生型STAT5(AdWT STAT5), STAT5显性负突变体(AdCMV5 Stat5a△740)以及STAT5 siRNA转染A549细胞, 并用EGF对后两组转染细胞加以刺激, 使STAT5及p-STAT5的表达发生变化, 再用RT-PCR检测A549细胞中的COX-2 mRNA表达。 在体外A549细胞中STAT5无激活; EGF可以诱导STAT5的激活, 促使磷酸化的STAT5穿梭入核; STAT5的激活是EGF诱导COX-2上调表达的必要条件; 非磷酸化的STAT5可能通过非转录激活的途径参与了COX-2表达的调控。 在A549细胞中STAT5可以通过磷酸化和非磷酸化两种途径来实现对COX-2的调控。
- 1 April 2013
- Vol. 16 (4) , 169-176
Open AccessEGF通过STAT5调控肺腺癌A549细胞中COX-2的机制
已有的研究表明COX-2在肺癌发生发展过程中起关键作用, 它被一些细胞因子和生长因子所诱导产生, 并受到JAK/STAT等信号通路的调控, 抑制COX-2的表达能阻止肺癌的发展。本研究旨在探讨表皮生长因子(epidermal growth factor, EGF)在人肺腺癌A549细胞中对STAT5激活效应, 以及STAT5信号通路对COX-2调控机制。 应用免疫荧光法及Western印迹法检测人肺腺癌A549细胞中EGF对STAT5的激活现象。分别用野生型STAT5(AdWT STAT5), STAT5显性负突变体(AdCMV5 Stat5a△740)以及STAT5 siRNA转染A549细胞, 并用EGF对后两组转染细胞加以刺激, 使STAT5及p-STAT5的表达发生变化, 再用RT-PCR检测A549细胞中的COX-2 mRNA表达。 在体外A549细胞中STAT5无激活; EGF可以诱导STAT5的激活, 促使磷酸化的STAT5穿梭入核; STAT5的激活是EGF诱导COX-2上调表达的必要条件; 非磷酸化的STAT5可能通过非转录激活的途径参与了COX-2表达的调控。 在A549细胞中STAT5可以通过磷酸化和非磷酸化两种途径来实现对COX-2的调控。
- Open Access
- 13 November 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 121
Fluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions
Background: The identification of malignant cells in effusions by conventional cytology is hampered by its limited sensitivity and specificity. The aim of this study was to investigate the value of fluorescence in situ hybridization (FISH) as adjuncts to conventional cytologic examination in patients with malignant pleural effusions. Methods: We conducted a retrospective cohort study of 93 inpatients with pleural effusions (72 malignant pleural effusions metastatic from 11 different organs and 21 benign) over 23 months. All the patients came from Chinese northeast areas. Aspirated pleural fluid underwent cytologic examination and fluorescence in situ hybridization (FISH) for aneuploidy. We used FISH in single-colour or if appropriate in dual-colour evaluation to detect chromosomal aberrations (chromosomes 7, 11, and 17) in effusion cells as markers of malignancy, to raise the diagnostic yield and identified the efficiency by diagnostic biopsy. Predominant cytogenetic anomalies and patterns of intratumor cytogenetic heterogeneity were brought in relation to overall survival rate. Results: Cytology alone confirmed malignant pleural effusions in 45 of 72 patients (sensitivity 63%), whereas FISH alone positively identified 48 of 72 patients (sensitivity 67%). Both tests had high specificity in predicting benign effusions. If cytology and FISH were considered together, they exhibited 88% sensitivity and 94.5% specificity in discriminating benign and malignant effusions. Combined, the two assays were more sensitive than either test alone. Although the positive predictive value of each test was 94.5%, the negative predictive value of cytology and FISH combined was 78%, better than 47% and 44% for FISH and cytology alone, respectively. There was a significantly prolonged survival rate for patients with aneuploidy for chromosome 17. Conclusions: FISH in combination with conventional cytology is a highly sensitive and specific diagnostic tool for detecting malignant cells in pleural effusions . The high sensitivity and specificity may be associated with geographic area and race. Simple numeric FISH anomalies may be prognostic.
- 13 November 2012
- Published by Springer Nature in Journal of Cardiothoracic Surgery
- Vol. 7 (1) , 121
Open AccessFluorescence in situ hybridization as adjunct to cytology improves the diagnosis and directs estimation of prognosis of malignant pleural effusions
Background: The identification of malignant cells in effusions by conventional cytology is hampered by its limited sensitivity and specificity. The aim of this study was to investigate the value of fluorescence in situ hybridization (FISH) as adjuncts to conventional cytologic examination in patients with malignant pleural effusions. Methods: We conducted a retrospective cohort study of 93 inpatients with pleural effusions (72 malignant pleural effusions metastatic from 11 different organs and 21 benign) over 23 months. All the patients came from Chinese northeast areas. Aspirated pleural fluid underwent cytologic examination and fluorescence in situ hybridization (FISH) for aneuploidy. We used FISH in single-colour or if appropriate in dual-colour evaluation to detect chromosomal aberrations (chromosomes 7, 11, and 17) in effusion cells as markers of malignancy, to raise the diagnostic yield and identified the efficiency by diagnostic biopsy. Predominant cytogenetic anomalies and patterns of intratumor cytogenetic heterogeneity were brought in relation to overall survival rate. Results: Cytology alone confirmed malignant pleural effusions in 45 of 72 patients (sensitivity 63%), whereas FISH alone positively identified 48 of 72 patients (sensitivity 67%). Both tests had high specificity in predicting benign effusions. If cytology and FISH were considered together, they exhibited 88% sensitivity and 94.5% specificity in discriminating benign and malignant effusions. Combined, the two assays were more sensitive than either test alone. Although the positive predictive value of each test was 94.5%, the negative predictive value of cytology and FISH combined was 78%, better than 47% and 44% for FISH and cytology alone, respectively. There was a significantly prolonged survival rate for patients with aneuploidy for chromosome 17. Conclusions: FISH in combination with conventional cytology is a highly sensitive and specific diagnostic tool for detecting malignant cells in pleural effusions . The high sensitivity and specificity may be associated with geographic area and race. Simple numeric FISH anomalies may be prognostic.